ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2012

Feb 22, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD RESEARCH CORP (ARWR)
CIK: 0000879407
Period of Report: 2012-02-16

Reporting Person: PERRY MICHAEL S (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-02-16	Stock Option	$5.19	A	15000	Disposed	2022-02-16	Common Stock (15000)	Direct

Footnotes

F1: Option vests one year from date of grant.